{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:47:56Z","timestamp":1790502476577,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009002.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T00:00:00Z","timestamp":1460332800000}}],"reference-count":121,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009002.pub3","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T08:18:43Z","timestamp":1460362723000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Omega-3 fatty acids for the treatment of dementia"],"prefix":"10.1002","volume":"2016","author":[{"given":"Marion","family":"Burckhardt","sequence":"first","affiliation":[{"name":"Martin Luther University Halle-Wittenberg; Institute of Health and Nursing Sciences, German Center for Evidence-based Nursing; Magdeburger Str. 27 Halle (Saale) Germany 06112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Herke","sequence":"additional","affiliation":[{"name":"Martin Luther University Halle-Wittenberg; Institute for Medical Sociology; Magdeburger Str. 27 Halle (Saale) Germany 06112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Wustmann","sequence":"additional","affiliation":[{"name":"Martin Luther University Halle-Wittenberg; Department of Psychiatry, Psychotherapy and Psychosomatics; Julius K\u00fchn Strasse 7 Halle (Saale) Germany 06112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Watzke","sequence":"additional","affiliation":[{"name":"Martin Luther University Halle-Wittenberg; Department of Psychiatry, Psychotherapy and Psychosomatics; Julius K\u00fchn Strasse 7 Halle (Saale) Germany 06112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gero","family":"Langer","sequence":"additional","affiliation":[{"name":"Martin Luther University Halle-Wittenberg; Institute for Health and Nursing Sciences; Magdeburger Strasse 8 Halle (Saale) Germany 06112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Fink","sequence":"additional","affiliation":[{"name":"Martin Luther University Halle-Wittenberg; Institute for Medical Sociology; Magdeburger Str. 27 Halle (Saale) Germany 06112"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,11]]},"reference":[{"issue":"4 Suppl","key":"10.1002\/14651858.CD009002.pub3-BIB0001|cit1","first-page":"P455","article-title":"Effects of omega-3 fatty acid supplementation on plasma fatty acids, gender effects, and effects on cognition in Alzheimer's patients: the OmegAD study","volume":"40","author":"Eriksdotter","year":"2014","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"10.1002\/14651858.CD009002.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JAD-150102","article-title":"Plasma fatty acid profiles in relation to cognition and gender in Alzheimer's disease patients during oral omega-3 fatty acid supplementation: the OmegAD study","volume":"48","author":"Eriksdotter","year":"2015","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1532-5415.2008.02055.x","article-title":"Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the Omega-3 Alzheimer's Disease study","volume":"57","author":"Faxen-Irving","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-121828","article-title":"Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study","volume":"36","author":"Faxen-Irving","year":"2013","journal-title":"Journal of Alzheimer's disease"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gps.1857","article-title":"Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms","volume":"23","author":"Freund-Levi","year":"2008","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0006|cit6","first-page":"9","article-title":"Oxidative stress and cox-mediated inflammation in patients with Alzheimer's disease and effects of N-3 fatty acid supplementation the omegAD study","volume":"Suppl","author":"Freund-Levi","year":"2011","journal-title":"Clinical Nutrition"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000218081","article-title":"Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study","volume":"27","author":"Freund-Levi","year":"2009","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0008|cit8","first-page":"S36","article-title":"Effects of a DHA rich omega-3 fatty acid supplementation for Alzheimer disease patients on fatty acid composition in cerebrospinal fluid, disease biomarkers and cognition: the OmegAD study","volume":"48","author":"Freund-Levi","year":"2012","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/joim.12166","article-title":"Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study","volume":"275","author":"Freund-Levi","year":"2014","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3233\/JAD-132042","article-title":"Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study","volume":"42","author":"Freund-Levi","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Freund-Levi Y Eriksdotter-Jonhagen M Cederholm T Basun H Faxen-Irving G Garlind Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study - a randomized double-blind trial Archives of Neurology 2006 1402 8","DOI":"10.1001\/archneur.63.10.1402"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0012|cit12","first-page":"11","article-title":"Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study [erratum appears in Journal of the American Geriatrics Society 2009;57(3):579]","volume":"57","author":"Irving","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0013|cit13","first-page":"Suppl 543.10","article-title":"N-3 fatty acid treatment and plasma transthyretin in patients with Alzheimer's disease","volume":"23","author":"Irving","year":"2009","journal-title":"FASEB Journal"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0014|cit14","first-page":"S36","article-title":"Effects of a DHA rich omega-3 fatty acid supplementation for Alzheimer disease patients on fatty acid composition in cerebrospinal fluid, disease biomarkers and cognition: the OmegAD study","volume":"48","author":"Levi Freund","year":"2012","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0015|cit15","first-page":"117","article-title":"Effects of a DHA rich omega-3 fatty acid supplementation on fatty acid composition in cerebrospinal fluid and relation to Alzheimer disease. The OmegAD study","volume":"Suppl","author":"Palmblad","year":"2011","journal-title":"Clinical Nutrition"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/ajcn\/87.6.1616","article-title":"Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study","volume":"87","author":"Vedin","year":"2008","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"e35425","DOI":"10.1371\/journal.pone.0035425","article-title":"Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study","volume":"7","author":"Vedin","year":"2012","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1194\/jlr.M002667","article-title":"Reduced prostaglandin F-2 alpha release from blood mononuclear leukocytes after oral supplementation of omega 3 fatty acids: the OmegAD study","volume":"51","author":"Vedin","year":"2010","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"lb343","DOI":"10.1096\/fasebj.27.1_supplement.lb343","article-title":"Effects of a DHA rich n-3 fatty acid supplementation on fatty acid composition in cerebrospinal fluid in Alzheimer disease. The OmegAD study","volume":"27","author":"Vedin","year":"2013","journal-title":"FASEB Journal"},{"issue":"3","key":"10.1002\/14651858.CD009002.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1194\/jlr.P055418","article-title":"Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study","volume":"56","author":"Wang","year":"2015","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0022|cit21","unstructured":"Quinn J Alzheimer's Disease Cooperative Study DHA primary analysis. Individual patient data (as supplied 22 May 2015) Data on file"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0023|cit22","first-page":"S1","article-title":"Effects of docosahexaenoic acid (DHA) in slowing the progression of Alzheimer's disease","volume":"31","author":"Quinn","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD009002.pub3-BIB0021|cit23","first-page":"P585","article-title":"Biomarkers of fatty acid oxidation in a clinical trial of DHA for Alzheimer's disease","volume":"8","author":"Quinn","year":"2012","journal-title":"Alzheimer's & Dementia"},{"issue":"17","key":"10.1002\/14651858.CD009002.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0026|cit25","unstructured":"Shinto L Unpublished six months results. Individual patient data (as supplied 16 July 2015) Data on file"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0025|cit26","doi-asserted-by":"crossref","unstructured":"Shinto L Quinn J Montine T Dodge HH Woodwarda W Baldauf-Wagnera S A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease Journal of Alzheimers Disease 2014","DOI":"10.3233\/JAD-130722"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0027|cit27","unstructured":"Carter J A randomised placebo-controlled trial of polyunsaturated omega-3 fatty acid (PFA), in the treatment of dementia; a pilot study, 2006 www.isrctn.com\/ISRCTN27372325"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1991.tb00228.x","article-title":"Essential fatty acids in Alzheimer's disease","volume":"640","author":"Corrigan","year":"1991","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD009002.pub3-BIB0030|cit30","first-page":"S610","article-title":"Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function in elderly people with very mild dementia in Japan","volume":"7","author":"Hashimoto","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"10.1002\/14651858.CD009002.pub3-BIB0031|cit31","first-page":"193","article-title":"Beneficial effects of daily dietary omega-3 polyunsaturated fatty acid supplementation on age-related cognitive decline in elderly Japanese with very mild dementia: a 2-year randomized, double-blind, placebo-controlled trial","volume":"1","author":"Hashimoto","year":"2012","journal-title":"Journal of Aging Research & Clinical Practice"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2251-6581-13-34","article-title":"Effect of low dose -3 poly unsaturated fatty acids on cognitive status among older people: a double-blind randomized placebo-controlled study","volume":"13","author":"Mahmoudi","year":"2014","journal-title":"Journal of Diabetes & Metabolic Disorders"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0033|cit33","unstructured":"NCT00867828 Multi-center, double-blind, placebo-controlled, monotherapy study of Neptune Krill Oil (NKO\u2122) in early stage Alzheimer's disease, 2009 clinicaltrials.gov\/show\/NCT00867828"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1007\/BF02562338","article-title":"Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases","volume":"34 Suppl","author":"Terano","year":"1999","journal-title":"Lipids"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0035|cit35","article-title":"Diagnostic and StatisticalManual of Mental Disorders","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0036|cit36","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0037|cit37","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1017\/S0007114512001444","article-title":"Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review","volume":"107 Suppl 2","author":"Aranceta","year":"2012","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamainternmed.2013.2299","article-title":"Why US adults use dietary supplements","volume":"173","author":"Bailey","year":"2013","journal-title":"JAMA International Medicine"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.neurobiolaging.2014.03.033","article-title":"Dietary and lifestyle guidelines for the prevention of Alzheimer's disease","volume":"35","author":"Barnard","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000051230","article-title":"The Gottfries-Br\u00e5ne-Steen scale: validity, reliability and application in anti-dementia drug trials","volume":"12","author":"Br\u00e5ne","year":"2001","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000017201","article-title":"Key methodological features of randomized controlled trials of Alzheimer's disease therapy","volume":"10","author":"Burback","year":"1999","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"3","key":"10.1002\/14651858.CD009002.pub3-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009002.pub2","article-title":"Omega 3 fatty acids for the treatment of dementia","author":"Burckhardt","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009002.pub3-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003833.pub4","article-title":"Omega-3 fatty acids for intermittent claudication","author":"Campbell","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.jalz.2007.10.005","article-title":"Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses","volume":"4","author":"Cansev","year":"2008","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.plefa.2009.05.015","article-title":"Omega-3 fatty acids and dementia","volume":"81","author":"Cole","year":"2009","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"12","key":"10.1002\/14651858.CD009002.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"5 Suppl 6","key":"10.1002\/14651858.CD009002.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The Neuropsychiatric Inventory: assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0050|cit50","unstructured":"Cummings J Neuropsychiatric Inventory (NPI) setting the standard for Alzheimer research: FAQs npitest.net\/faqs.html"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0051|cit51","doi-asserted-by":"crossref","unstructured":"Dennis CL Dowswell T Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression Cochrane Database of Systematic Reviews 2013 10.1002\/14651858.CD006795.pub3","DOI":"10.1002\/14651858.CD006795.pub3"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/07315724.2013.875423","article-title":"Consumer usage and reasons for using dietary supplements: report of a series of surveys","volume":"33","author":"Dickinson","year":"2014","journal-title":"Journal of the American College of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD009002.pub3-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1185\/030079908X291958","article-title":"The clinical relevance of changes in the Montgomery-\u00c5sberg Depression Rating Scale using the minimum clinically important difference approach","volume":"24","author":"Duru","year":"2008","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD009002.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2013.282834","article-title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial","volume":"311","author":"Dysken","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD009002.pub3-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2903\/j.efsa.2010.1461","article-title":"Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol","volume":"8","author":"EFSA Panel on Dietetic","year":"2010","journal-title":"EFSA Journal"},{"issue":"7","key":"10.1002\/14651858.CD009002.pub3-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.2903\/j.efsa.2012.2815","article-title":"Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)","volume":"10","author":"European Food Safety Authority (EFSA)","year":"2012","journal-title":"EFSA Journal"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0058|cit58","unstructured":"European Medicines Agency: Committee for Medicinal Products for Human Use (CHMP) Discussion paper on the clinical investigation of medicines for the treatment of Alzheimer's disease and other dementias. EMA\/CHMP\/539931\/2014 Corr www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/10\/WC500176827.pdf"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0059|cit59","unstructured":"Thomson Reuters EndNote X5 2011"},{"issue":"Suppl","key":"10.1002\/14651858.CD009002.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"197S","DOI":"10.1093\/ajcn\/71.1.197S","article-title":"Safety considerations of polyunsaturated fatty acids","volume":"71","author":"Eritsland","year":"2000","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0061|cit61","unstructured":"Food Agriculture Organization of the United Nations (FAO) Fats and fatty acids in human nutrition. Report of an expert consultation. 10-14 November 2008, Geneva FAO Food and Nutrition Paper 91 2010 188"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0062|cit62","unstructured":"Fillenbaum GG OARS multidimensional functional assessment questionnaire complete activities of daily living section (ADL, IADL, Summary Scale), 1975 www.dementia-assessment.com.au\/symptoms\/oars_adl_iadl.pdf"},{"issue":"4","key":"10.1002\/14651858.CD009002.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/geronj\/36.4.428","article-title":"The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire","volume":"36","author":"Fillenbaum","year":"1981","journal-title":"Journal of Gerontology"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009002.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Disease & Associated Disorders"},{"issue":"5","key":"10.1002\/14651858.CD009002.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5014\/ajot.53.5.471","article-title":"Development of a functional measure for persons with Alzheimer's disease: the Disability Assessment for Dementia","volume":"53","author":"Gelinas","year":"1999","journal-title":"American Journal of Occupational Therapy"},{"issue":"9","key":"10.1002\/14651858.CD009002.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1532-5415.1985.tb06317.x","article-title":"OARS methodology. A decade of experience in geriatric assessment","volume":"33","author":"George","year":"1985","journal-title":"Journal of the American Geriatrics Society"},{"issue":"4","key":"10.1002\/14651858.CD009002.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD009002.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archneur.64.9.1323","article-title":"A neuropsychological test battery for use in Alzheimer disease clinical trials","volume":"64","author":"Harrison","year":"2007","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD009002.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003205.pub2","article-title":"Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus","author":"Hartweg","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD009002.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/jnnp.2006.109074","article-title":"Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination","volume":"78","author":"Hensel","year":"2007","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0072|cit72","unstructured":"Higgins JPT Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0073|cit73","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD009002.pub3-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003177.pub2","article-title":"Omega 3 fatty acids for prevention and treatment of cardiovascular disease","author":"Hooper","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009002.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/gps.2607","article-title":"Determining the minimum clinically important differences for outcomes in the DOMINO trial","volume":"26","author":"Howard","year":"2011","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0076|cit76","volume-title":"Pharmaceutical and non-pharmaceutical interventions for Alzheimer's Disease, a rapid assessment","author":"Hulstaert","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD009002.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"e005247","DOI":"10.1136\/bmjopen-2014-005247","article-title":"Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression","volume":"5","author":"Huntley","year":"2015","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0078|cit78","volume-title":"Positronenemissionstomographie (PET) und PET\/CT bei Alzheimer-Demenz. Berichtsplan Version 1.0. Available from www.iqwig.de","author":"Institute for Quality and Efficiency in Health Care (IQWIG)","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD009002.pub3-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001257.pub2","article-title":"Polyunsaturated fatty acid supplementation for schizophrenia","author":"Irving","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMp1311405","article-title":"New insights into the dementia epidemic","volume":"369","author":"Larson","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009002.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010015.pub3","article-title":"Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration","author":"Lawrenson","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009002.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD009002.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4088\/JCP.11r07546","article-title":"A meta-analytic review of polyunsaturated fatty acid compositions in dementia","volume":"73","author":"Lin","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD009002.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00006842-200205000-00016","article-title":"Assessing quality of life in older adults with cognitive impairment","volume":"64","author":"Logsdon","year":"2002","journal-title":"Psychosomatic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009002.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jalz.2013.05.1771","article-title":"Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis","volume":"10","author":"Lopes da Silva","year":"2013","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"g2272","DOI":"10.1136\/bmj.g2272","article-title":"Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys","volume":"348","author":"Micha","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"Mohs RC Knopman D Petersen RC Ferris SH Ernesto C Grundman M Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 1997","DOI":"10.1097\/00002093-199700112-00003"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.3390\/nu6104058","article-title":"The role for dietary omega-3 fatty acids supplementation in older adults","volume":"6","author":"Molfino","year":"2014","journal-title":"Nutrients"},{"issue":"8","key":"10.1002\/14651858.CD009002.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1503\/cmaj.080820","article-title":"Does analysis using \"last observation carried forward\" introduce bias in dementia research?","volume":"179","author":"Molnar","year":"2008","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1532-5415.2008.02122.x","article-title":"Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia","volume":"57","author":"Molnar","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009002.pub3-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005169.pub2","article-title":"Omega-3 fatty acids for bipolar disorder","author":"Montgomery","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.neurobiolaging.2014.03.038","article-title":"Dietary fat composition and dementia risk","volume":"35 Suppl 2","author":"Morris","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"563160","DOI":"10.1155\/2014\/563160","article-title":"Effects of diet on brain plasticity in animal and human studies: mind the gap","volume":"2014","author":"Murphy","year":"2014","journal-title":"Neural Plasticity"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.acn.2004.03.010","article-title":"Detecting depression in Alzheimer's disease: evaluation of four different scales","volume":"20","author":"M\u00fcller-Thomsen","year":"2005","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"8","key":"10.1002\/14651858.CD009002.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","article-title":"Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's Research Consortium study","volume":"65","author":"O'Bryant","year":"2008","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009002.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-148-5-200803040-00008","article-title":"Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians","volume":"148","author":"Qaseem","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00391-012-0346-y","article-title":"Malnutrition and dementia in the elderly in German nursing homes. Results of a prevalence survey from the years 2008 and 2009","volume":"46","author":"Reuther","year":"2013","journal-title":"Zeitschrift f\u00fcr Gerontologie und Geriatrie"},{"issue":"2","key":"10.1002\/14651858.CD009002.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0102|cit102","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD009002.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12603-012-0401-9","article-title":"Malnutrition in community-dwelling adults with dementia (NutriAlz Trial)","volume":"17","author":"Roque","year":"2013","journal-title":"Journal of Nutrition, Health and Aging"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0106|cit106","unstructured":"Schmidt M Rey Auditory Verbal Learning Test\u2122 (RAVLT\u2122). A handbook, 1996 www.wpspublish.com\/app\/"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","volume":"11 Suppl 2","author":"Schneider","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp-2011-300881","article-title":"What is the clinically relevant change on the ADAS-Cog?","volume":"83","author":"Schrag","year":"2012","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0109|cit109","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0110|cit110","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A (editors) GRADE handbook for grading quality of evidence and strength of recommendations. Chapter 5. Updated October 2013 gdt.guidelinedevelopment.org\/central_prod\/_design\/client\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jnutbio.2009.11.003","article-title":"Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance","volume":"21","author":"Su","year":"2010","journal-title":"Journal of Nutritional Biochemistry"},{"issue":"6","key":"10.1002\/14651858.CD009002.pub3-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005379.pub3","article-title":"Omega 3 fatty acid for the prevention of cognitive decline and dementia","author":"Sydenham","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0113|cit113","unstructured":"United Nations Department of Economic and Social Affairs Population Division World Population Ageing 2013 www.un.org\/en\/development\/desa\/population\/publications\/"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0114|cit114","unstructured":"US Preventive Task Force Screening for cognitive impairment in older adults: final recommendation statement. AHRQ Publication No. 14-05198-EF-2, 2014 www.uspreventiveservicestaskforce.org\/uspstf14\/dementia\/dementiafinalrs.htm"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"e35425","DOI":"10.1371\/journal.pone.0035425","article-title":"Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study","volume":"7","author":"Vedin","year":"2012","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0116|cit116","first-page":"75","article-title":"Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment","volume":"9","author":"Vellas","year":"2005","journal-title":"Journal of Nutrition, Health and Aging"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1474-4422(08)70087-5","article-title":"Endpoints for trials in Alzheimer's disease: a European task force consensus","volume":"7","author":"Vellas","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0118|cit118","volume-title":"Wechsler Memory Scale","author":"Wechsler","year":"2010"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0119|cit119","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0120|cit120","volume-title":"International Statistical Classification of Diseases and Related Health Problems, 10th revision","volume":"2","author":"World Health Organization","year":"2010"},{"key":"10.1002\/14651858.CD009002.pub3-BIB0121|cit121","unstructured":"World Health Organization Alzheimer's Disease International Dementia. A public health priority, 2012 Available from www.who.int\/mental_health\/publications\/dementia_report_2012\/en\/"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009002.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T03:13:13Z","timestamp":1660878793000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009002.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,11]]},"references-count":121,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009002.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,11]]}}}